Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rano Matta

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Urology|January 29, 2023
Variation in Provider Practice Patterns and the Perceived Need for a Shared Decision-making Tool for Neurogenic Lower Urinary Tract DysfunctionKiarad Fendereski, Kevin J Hebert, Rano Matta, et al.
European Urology Focus|November 7, 2021
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control StudyRano Matta, Tara Gomes, David Juurlink, et al.
Organogenesis|January 4, 2011
Development, characterization and clinical use of a biodegradable composite scaffold for bone engineering in oro-maxillo-facial surgeryJohn E Davies, Rano Matta, Vanessa C Mendes, et al.
Urology Practice|May 5, 2023
Impact of Delayed Recognition of Iatrogenic Ureteral Injury in a Retrospective Population-Based StudyJennifer A Locke, Rano Matta, Refik Saskin, et al.
European Urology Focus|April 29, 2023
Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical TrialsRano Matta, Refik Saskin, Sarah Neu, et al.
JAMA Internal Medicine|July 16, 2019
Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort StudyMina Tadrous, Rano Matta, Simon Greaves, et al.
Clinical Genitourinary Cancer|September 5, 2024
The Incidence of Extreme Serum Prostate Specific Antigen Levels During the COVID-19 PandemicAmanda E Hird, Rano Matta, Refik Saskin, et al.
Urology|May 6, 2022
National Trends and Outcomes in the Use of Intravesical Botulinum Toxin and Enterocystoplasty Among Patients With MyelomeningoceleRano Matta, Joshua J Horns, Deborah L Jacobson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancerAlaina Garbens, Christopher J D Wallis, Rano Matta, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation modelAmanda E Hird, Diana E Magee, Douglas C Cheung, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Urology|January 29, 2023
Variation in Provider Practice Patterns and the Perceived Need for a Shared Decision-making Tool for Neurogenic Lower Urinary Tract DysfunctionKiarad Fendereski, Kevin J Hebert, Rano Matta, et al.
European Urology Focus|November 7, 2021
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control StudyRano Matta, Tara Gomes, David Juurlink, et al.
Organogenesis|January 4, 2011
Development, characterization and clinical use of a biodegradable composite scaffold for bone engineering in oro-maxillo-facial surgeryJohn E Davies, Rano Matta, Vanessa C Mendes, et al.
Urology Practice|May 5, 2023
Impact of Delayed Recognition of Iatrogenic Ureteral Injury in a Retrospective Population-Based StudyJennifer A Locke, Rano Matta, Refik Saskin, et al.
European Urology Focus|April 29, 2023
Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical TrialsRano Matta, Refik Saskin, Sarah Neu, et al.
JAMA Internal Medicine|July 16, 2019
Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort StudyMina Tadrous, Rano Matta, Simon Greaves, et al.
Clinical Genitourinary Cancer|September 5, 2024
The Incidence of Extreme Serum Prostate Specific Antigen Levels During the COVID-19 PandemicAmanda E Hird, Rano Matta, Refik Saskin, et al.
Urology|May 6, 2022
National Trends and Outcomes in the Use of Intravesical Botulinum Toxin and Enterocystoplasty Among Patients With MyelomeningoceleRano Matta, Joshua J Horns, Deborah L Jacobson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancerAlaina Garbens, Christopher J D Wallis, Rano Matta, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation modelAmanda E Hird, Diana E Magee, Douglas C Cheung, et al.
Pageof 5